Table 3.
Co-morbidities (% of each stone type)
| CYSF | NCSF | Total | |
|---|---|---|---|
| Anemia | 21 (10) | 4 (5) | 25 |
| Anxiety | 30 (14) | 8 (10) | 38 |
| Arthritis* | 18 (18) | 14 (14) | 32 |
| Asthma | 19 (9) | 3 (4) | 22 |
| Back, shoulder, or knee problems | 33 (15) | 15 (19) | 48 |
| Cancer* | 2 (1) | 6 (7) | 8 |
| Chronic bronchitis | 3 (1) | 2 (3) | 5 |
| Chronic pain* | 36 (17) | 6 (7) | 42 |
| Depression | 35 (16) | 10 (12) | 45 |
| DM | 9 (4) | 9 (11) | 18 |
| Epilepsy | 0 (0) | 1 (1) | 1 |
| Family history of kidney stones | 52 (24) | 19 (24) | 71 |
| Headaches* | 31 (15) | 2 (3) | 33 |
| Heartburn* | 5 (2) | 7 (9) | 12 |
| Hepatitis | 3 (1) | 1 (1) | 4 |
| High blood pressure | 53 (25) | 25 (31) | 78 |
| High cholesterol* | 35 (16) | 25 (31) | 60 |
| Infertility | 5 (2) | 2 (3) | 7 |
| Nasal allergies | 19 (9) | 7 (9) | 26 |
| Obesity | 32 (15) | 9 (11) | 41 |
| Overactive thyroid | 2 (1) | 2 (3) | 4 |
| Underactive thyroid* | 4 (2) | 6 (7) | 10 |
CYSF cystine stone formers, NCSF non-cystine stone formers
*
p < 0.05 by Fishers exact test